STOCK TITAN

Accenture plc Form 4 Filings

ACN NYSE

Every Form 4 that Accenture plc (ACN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACN filings page.

Rhea-AI Summary

Accenture plc Chief Operating Officer Catherine Kiernan Hogan sold 700 Class A ordinary shares on October 12, 2026, pursuant to a Rule 10b5-1 Trading Plan. A separate holding entry reports 2,048 Class A ordinary shares held indirectly in a Family Trust.

Rhea-AI Summary

Accenture plc Chief Operating Officer Catherine Kiernan Hogan reported selling 1,320 Class A ordinary shares at $200 per share on October 8, 2026, pursuant to a Rule 10b5-1 Trading Plan. After the sale, she held 12,556 shares directly; her reported holdings also included 2,048 shares held in a Family Trust.

Rhea-AI Summary

Accenture plc Chief Accounting Officer Melissa A. Burgum acquired 101 Class A ordinary shares on October 5, 2026, at $196.755 per share. Her reported direct holdings after the transaction were 10,107 shares.

Rhea-AI Summary

Accenture plc CFO Angie Y. Park acquired 140 Class A ordinary shares on October 5, 2026, in a purchase from Accenture under the Accenture Voluntary Equity Investment Program. The reported price was $196.7550 per share; Park’s reported direct holdings following the transaction were 13,790 shares.

Rhea-AI Summary

Accenture plc Chair and CEO Julie Spellman Sweet acquired 197 Class A ordinary shares on October 5, 2026, through a purchase from Accenture under the Accenture Voluntary Equity Investment Program. The reported price was $196.7550 per share; her direct holdings following the transaction were 17,196 Class A ordinary shares.

Rhea-AI Summary

Accenture plc (ACN) Chief Operating Officer Catherine Kiernan Hogan acquired 109 Class A ordinary shares on October 5, 2026, at $196.7550 per share through a purchase from Accenture under the Accenture Voluntary Equity Investment Program. No Rule 10b5-1 plan is reported for the transaction. Her direct holdings following the transaction were 13,876 shares; she also reported 2,048 shares held indirectly in a Family Trust.

Rhea-AI Summary

Accenture plc General Counsel/Corp Secretary Joel Unruch acquired 140 Class A ordinary shares on October 5, 2026, at $196.7550 per share. He acquired them through a purchase from Accenture under the Accenture Voluntary Equity Investment Program. His directly held position after the transaction was 18,270 shares.

Rhea-AI Summary

Accenture plc Chief Leadership & HR Officer Katherine Lee Clifford acquired 89 Class A ordinary shares on October 5, 2026, at $196.7550 per share. The shares were purchased from Accenture through the Accenture Voluntary Equity Investment Program. Her reported direct holdings after the transaction were 6,993 shares.

Rhea-AI Summary

Accenture plc’s Chief Strategy & Services Ofcr Manish Sharma acquired 93 Class A ordinary shares on October 5, 2026, at $196.7550 per share through a purchase from Accenture under its Voluntary Equity Investment Program. His directly held position following the transaction was 5,994 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Accenture plc reports that John F. Walsh, CEO-The Americas, acquired 139 Class A ordinary shares on October 5, 2026, at $196.755 per share. A footnote describes the transaction as a purchase from Accenture under its Voluntary Equity Investment Program. Walsh’s directly held position following the transaction was 26,395 shares.

Rhea-AI Summary

Accenture plc (ACN) reported that Chair and CEO Julie Spellman Sweet acquired 205 Class A ordinary shares of Accenture on September 5, 2026 at $189.095 per share through a grant/award-type transaction. The purchase was made from Accenture under its Voluntary Equity Investment Program, bringing her direct holdings to 16,999 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Accenture plc (ACN) reports that John F. Walsh, its CEO-The Americas, acquired 146 Class A ordinary shares on September 5, 2026 at $189.10 per share. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program, bringing his direct holdings to 26,256 shares.

Rhea-AI Summary

Accenture plc (ACN) reports that General Counsel and Corporate Secretary Joel Unruch acquired 145 Class A ordinary shares on September 5, 2026 through a grant or award transaction. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program at $189.095 per share, bringing his directly held stake to 18,130 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Accenture plc (ACN) reported that its Chief Financial Officer, Angie Y. Park, acquired 145 Class A ordinary shares on September 5, 2026 through a grant/award-type acquisition. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program, bringing her direct holdings to 13,650 shares.

Rhea-AI Summary

Accenture plc (ACN) reported that Chief Strategy & Services Officer Manish Sharma acquired 97 Class A ordinary shares on September 5, 2026 through a grant or award transaction priced at $189.095 per share. Following this acquisition, Sharma directly holds 5,901 Class A ordinary shares of Accenture.

According to the footnote, the transaction reflects a purchase of Accenture Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Accenture plc (ACN) reported that Chief Accounting Officer Melissa A. Burgum acquired 106 Class A ordinary shares of Accenture on September 5, 2026 through a grant/award transaction under the Accenture Voluntary Equity Investment Program at a reference price of $189.10 per share, bringing her direct holdings to 10,006 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Accenture plc (ACN) reported that Chief Leadership & HR Officer Katherine Lee Clifford acquired 92 Class A ordinary shares on September 5, 2026. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program at $189.095 per share, bringing her direct holdings to 6,904 shares. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Accenture plc (ACN) reports that Chief Operating Officer Catherine Kiernan Hogan acquired 113 Class A ordinary shares on September 5, 2026 through a purchase from Accenture under the Accenture Voluntary Equity Investment Program at $189.095 per share. Following this purchase, she holds 13,767 shares directly and 2,048 shares indirectly in a family trust. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Accenture plc (ACN) reported that Chief Accounting Officer Melissa A. Burgum acquired 1,034 Class A ordinary shares on August 1, 2026 through a grant of restricted share units at a stated price of $0.00 per share, increasing her directly held stake to 9,760 shares.

The amendment explains that an earlier Form 4 had incorrectly shown the grant as 778 restricted share units and post-transaction holdings as 9,504 shares; this filing corrects those figures. The transactions were not marked as pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Walsh John F reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc executive John F. Walsh, CEO-The Americas, received an award of 24 Class A ordinary shares on 2026-08-14. The award reflects a grant of Restricted Share Units (RSUs) under anti-dilution provisions tied to Accenture’s payment of a cash dividend. Following this grant, Walsh directly holds 26,110 Class A shares.

Rhea-AI Summary

Accenture plc director Martin Brudermueller reported an acquisition of 9 Class A ordinary shares on 2026-08-14. The award was a grant of Restricted Share Units (RSUs) made under anti-dilution provisions to reflect Accenture’s payment of a cash dividend. Following this grant, Brudermueller beneficially owns 1,690 Class A shares in direct holdings.

Rhea-AI Summary

Travis Tracey Thomas reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc director Travis Tracey Thomas reported an automatic grant of 15 Class A ordinary shares on August 14, 2026. The footnote explains this was a grant of Restricted Share Units under anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Following this award, Thomas directly holds 9,829 Class A ordinary shares of Accenture.

Rhea-AI Summary

Accenture plc officer Melissa A. Burgum, Chief Accounting Officer, reported an acquisition of 23 Class A ordinary shares in the form of restricted share units. The grant was made under the anti-dilution provisions of previously granted RSU awards to reflect Accenture plc's payment of a cash dividend. Following this award, Burgum directly holds 9,644 Class A ordinary shares. The transaction was reported as a grant or other acquisition, with no price paid per share.

Rhea-AI Summary

Accenture plc director Jennifer Nason received a grant of 9 Class A ordinary shares on 2026-08-14, reported as a grant/award acquisition at $0.00 per share. This reflects anti-dilution Restricted Share Units (RSUs) issued to adjust for Accenture’s payment of a cash dividend. Following the grant, she directly holds 932 Class A shares and indirectly holds 403 Class A shares through an LLC.

Rhea-AI Summary

Uotani Masahiko reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc director Masahiko Uotani reported an award of 9 Class A ordinary shares on August 14, 2026. The award represents Restricted Share Units (RSUs) granted under anti-dilution provisions to reflect Accenture's payment of a cash dividend. Following this grant, Uotani holds 1,258 Class A shares directly.

Rhea-AI Summary

Accenture plc executive Joel Unruch, General Counsel and Corporate Secretary, reported an acquisition of 88 Class A ordinary shares on 2026-08-14. The shares were granted as Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend, bringing his directly held total to 17,985 shares.

Rhea-AI Summary

Accenture plc director Nancy McKinstry reported an acquisition of 12 Class A ordinary shares on 2026-08-14 through a grant of Restricted Share Units (RSUs). The RSUs were issued under anti-dilution provisions tied to Accenture plc's payment of a cash dividend. Following this award, McKinstry directly holds 8,107 Class A ordinary shares.

Rhea-AI Summary

Sweet Julie Spellman reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc reported that Chair and CEO Julie Spellman Sweet received an automatic grant of 47 Class A ordinary shares on 2026-08-14. The award reflects Restricted Share Units (RSUs) issued under anti-dilution provisions tied to Accenture’s payment of a cash dividend. Following this grant, her directly held Class A ordinary share position increased to 16,794 shares. The shares were granted at a reported price of $0.00 per share, consistent with a compensation-related equity award rather than an open-market purchase.

Rhea-AI Summary

Accenture plc director Paula A. Price reported an acquisition of 14 Class A ordinary shares in the form of Restricted Share Units (RSUs) on 2026-08-14. The RSUs were granted under the anti-dilution provisions of previously granted RSU awards to reflect Accenture’s payment of a cash dividend. Following this adjustment grant, Price directly holds 8,561 Class A ordinary shares. The transaction was a compensation-related award rather than an open-market trade.

Rhea-AI Summary

Accenture plc executive Katherine Lee Clifford, Chief Leadership & HR Officer, reported two equity transactions in Class A ordinary shares of ACN. She received an award of 50 RSU-linked shares at $0.00 per share, increasing her directly held position to 6,812 shares. The award reflects anti-dilution provisions tied to Accenture’s cash dividend. On the same date, 68 shares indirectly held by an immediate family member were sold at $175.975 per share, leaving no reported indirect holdings from that position.

Rhea-AI Summary

Accenture plc executive Catherine Kiernan Hogan, Chief Operating Officer, reported an acquisition of 50 Class A ordinary shares on 2026-08-14. The shares were granted at $0.0000 per share as part of a Restricted Share Unit (RSU) adjustment under anti-dilution provisions tied to Accenture’s cash dividend. Following this grant, she holds 13,654 Class A shares directly, and a separate 2,048 shares are held indirectly through a Family Trust.

Rhea-AI Summary

Accenture plc (ACN) director Arun Sarin reported an acquisition of 13 Class A ordinary shares on 2026-08-14 through a grant of Restricted Share Units (RSUs). The RSUs were issued under anti-dilution provisions to reflect Accenture's payment of a cash dividend. Following this grant, Sarin directly holds 9,627 shares of Accenture.

Rhea-AI Summary

Accenture plc director Venkata S M Renduchintala reported an acquisition of 9 Class A ordinary shares on 2026-08-14. The shares were granted as Restricted Share Units (RSUs) at a stated price of $0.00 per share, pursuant to anti-dilution provisions tied to Accenture’s payment of a cash dividend. Following this RSU-related adjustment, his directly held position increased to 4,419 Class A ordinary shares.

Rhea-AI Summary

Accenture plc officer Manish Sharma, Chief Strategy & Services Officer, reported an acquisition of 17 Class A ordinary shares on 2026-08-14 through a grant of Restricted Share Units (RSUs). The filing states this RSU grant arose from anti-dilution provisions triggered by Accenture plc's payment of a cash dividend, bringing his directly held shares to 5,804.

Rhea-AI Summary

Park Angie Y reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc reported that Chief Financial Officer Angie Y. Park received an award of 23 Class A ordinary shares on August 14, 2026. The filing describes this as a grant of Restricted Share Units pursuant to anti-dilution provisions tied to Accenture’s cash dividend, bringing her directly held stake to 13,505 shares.

Rhea-AI Summary

Jope Alan C. reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc director Alan C. Jope received a grant of 14 Class A ordinary shares in the form of Restricted Share Units. The award was made under anti-dilution provisions tied to previously granted RSU awards to reflect Accenture plc’s payment of a cash dividend. Following this grant, Jope directly holds 3,223 Class A ordinary shares.

Rhea-AI Summary

Accenture plc reports that Chief Strategy & Services Officer Manish Sharma acquired 107.0000 Class A ordinary shares on 2026-08-05 at $170.3525 per share, purchasing them from Accenture under its Voluntary Equity Investment Program. Following this transaction, he directly holds 5787.0000 shares.

Rhea-AI Summary

Accenture plc reports that Chief Financial Officer Angie Y Park acquired 162 Class A ordinary shares on 2026-08-05 at $170.3525 per share. The shares were purchased from Accenture under its Voluntary Equity Investment Program, bringing her direct holdings to 13,482 shares. The transaction was not designated as pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Accenture plc General Counsel and Corporate Secretary Joel Unruch acquired 162 Class A ordinary shares on 2026-08-05 at $170.3525 per share. The shares were purchased from Accenture under its Accenture Voluntary Equity Investment Program. After this acquisition, he directly holds 17,897 Class A ordinary shares.

Rhea-AI Summary

Accenture plc reports that John F. Walsh, CEO-The Americas, acquired 161 Class A ordinary shares on 2026-08-05 at $170.3525 per share under the Accenture Voluntary Equity Investment Program, purchasing the shares from Accenture. Following this acquisition, he directly holds 26086 shares.

Rhea-AI Summary

Accenture plc reported that Chief Leadership & HR Officer Katherine Lee Clifford acquired 103 Class A ordinary shares on 2026-08-05 at $170.3525 per share through a purchase from Accenture under the Accenture Voluntary Equity Investment Program. After this transaction she directly held 6762 shares and indirectly held 68 shares held by an immediate family member.

Rhea-AI Summary

Accenture plc Chief Accounting Officer Melissa A. Burgum reported acquiring 117 Class A ordinary shares on August 5, 2026 at $170.3525 per share. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program, bringing her direct holdings to 9,621 Class A shares.

Rhea-AI Summary

Catherine Kiernan Hogan, Chief Operating Officer of Accenture, acquired 126 Class A ordinary shares on 2026-08-05 at $170.3525 per share, purchasing them from Accenture under its Voluntary Equity Investment Program. After this transaction she holds 13,604 shares directly and 2,048 shares indirectly through a Family Trust.

Rhea-AI Summary

Accenture plc Chair and CEO Julie Sweet acquired 227 Class A ordinary shares on 2026-08-05 at $170.3525 per share. The shares were purchased from Accenture under the Accenture Voluntary Equity Investment Program, increasing her direct ownership to 16,747 shares.

Rhea-AI Summary

Burgum Melissa A reported acquisition or exercise transactions in this Form 4 filing.

Accenture plc granted Chief Accounting Officer Melissa A. Burgum an equity award of 778 Class A ordinary shares in the form of restricted share units on August 1, 2026, under the Accenture plc Amended and Restated 2010 Share Incentive Plan, increasing her direct holdings to 9,504 shares.

Rhea-AI Summary

Joel Unruch, General Counsel and Corporate Secretary of Accenture plc, reported selling 10,498 Class A ordinary shares on July 30, 2026 in five transactions. The sales occurred at weighted‑average prices per share of $160.8633, $162.2949, $163.2708, $164.4409 and $165.1631, and were effected pursuant to a Rule 10b5-1 Trading Plan, with each price reflecting multiple trades within a stated range.

Rhea-AI Summary

Accenture plc General Counsel Joel Unruch reported acquiring 202 Class A ordinary shares of Accenture. The shares were obtained at a price of $135.92 per share and were purchased from Accenture under the Accenture Voluntary Equity Investment Program. Following this transaction, he holds 28,233 Class A ordinary shares directly.

Rhea-AI Summary

Accenture plc reported that Chair and CEO Julie Sweet acquired 285 Class A ordinary shares. The shares were obtained on 2026-07-05 at $135.92 per share through a purchase from Accenture under its Voluntary Equity Investment Program. Following this acquisition, she directly holds 16,520 Class A shares.

Rhea-AI Summary

Accenture plc Chief Leadership & HR Officer Katherine Lee Clifford reported an acquisition of Class A ordinary shares. She received 128 shares from Accenture at $135.92 per share under the Accenture Voluntary Equity Investment Program, increasing her direct holdings to 6,659 shares. The filing also reports 68 shares indirectly owned through an immediate family member.

Rhea-AI Summary

Accenture plc Chief Operating Officer Catherine Kiernan Hogan acquired 157 Class A ordinary shares from Accenture at $135.92 per share under the Accenture Voluntary Equity Investment Program. This was reported as a grant or other acquisition, reflecting compensation-related share ownership rather than an open-market purchase.

Following this transaction, Hogan directly holds 13,478 Class A shares. Separately, 2,048 Class A shares are held indirectly in a family trust, showing additional indirect exposure to Accenture equity alongside her direct holdings.